Evidence map›Paper›PMID 25086047›Full record

ArticleThe Journal of biological chemistry2014

Misfolded proteins induce aggregation of the lectin Yos9.

Melanie H Smith, Edwin H Rodriguez, Jonathan S Weissman

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Htm1p-Pdi1p is a folding-sensitive mannosidase that marks N-glycoproteins for ER-associated protein degradation.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  5. Glycosylation-directed quality control of protein folding.Nature reviews. Molecular cell biology · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Melanie H SmithFrom the Department of Cellular and Molecular Pharmacology, Graduate Group in Biophysics, California Institute for Quantitative Biosciences, Center for RNA Systems Biology, and Howard Hughes Medical Institute, University of California at San Francisco, San Francisco, California 94158.
Edwin H RodriguezFrom the Department of Cellular and Molecular Pharmacology, Graduate Group in Biophysics, California Institute for Quantitative Biosciences, Center for RNA Systems Biology, and Howard Hughes Medical Institute, University of California at San Francisco, San Francisco, California 94158.
Jonathan S WeissmanFrom the Department of Cellular and Molecular Pharmacology, Graduate Group in Biophysics, California Institute for Quantitative Biosciences, Center for RNA Systems Biology, and Howard Hughes Medical Institute, University of California at San Francisco, San Francisco, California 94158 Jonathan.Weissman@ucsf.edu.
University of California, San Francisco · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007618 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ANDERSON, MARK S · 1985 to 2020
$29.6M
STRUCTURAL BIOLOGY TRAINING PROGRAMT32GM008284 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KORTEMME, TANJA · 1988 to 2022
$10.1M
Structural Basis of Protein HomeostasisU01GM098254 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI AGARD, DAVID A., FRYDMAN, JUDITH · 2012 to 2014
$3.2M
Howard Hughes Medical InstituteNIGMS NIH HHS T32 GM007618NIGMS NIH HHS T32 GM008284NIGMS NIH HHS U01 GM098254
6 · The paper itself

Abstract

A substantial fraction of nascent proteins delivered into the endoplasmic reticulum (ER) never reach their native conformations. Eukaryotes use a series of complementary pathways to efficiently recognize and dispose of these terminally misfolded proteins. In this process, collectively termed ER-associated degradation (ERAD), misfolded proteins are retrotranslocated to the cytosol, polyubiquitinated, and degraded by the proteasome. Although there has been great progress in identifying ERAD components, how these factors accurately identify substrates remains poorly understood. The targeting of misfolded glycoproteins in the ER lumen for ERAD requires the lectin Yos9, which recognizes the glycan species found on terminally misfolded proteins. In a role that remains poorly characterized, Yos9 also binds the protein component of ERAD substrates. Here, we identified a 45-kDa domain of Yos9, consisting of residues 22-421, that is proteolytically stable, highly structured, and able to fully support ERAD in vivo. In vitro binding studies show that Yos9(22-421) exhibits sequence-specific recognition of linear peptides from the ERAD substrate, carboxypeptidase Y G255R (CPY*), and binds a model unfolded peptide ΔEspP and protein Δ131Δ in solution. Binding of Yos9 to these substrates results in their cooperative aggregation. Although the physiological consequences of this substrate-induced aggregation remain to be seen, it has the potential to play a role in the regulation of ERAD.

Indexed as

Endoplasmic Reticulum-Associated DegradationCarrier ProteinsCathepsin AEndoplasmic ReticulumGlycoproteinsLectinsMolecular ChaperonesProtein FoldingProteolysisSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsUbiquitinationCarrier ProteinsCathepsin AGlycoproteinsLectinsMolecular Chaperonesnascent-polypeptide-associated complexSaccharomyces cerevisiae ProteinsYos9 protein, S cerevisiaeAggregationCarbohydrate-binding ProteinCPY*Endoplasmic Reticulum-associated Protein Degradation (ERAD)Endoplasmic Reticulum (ER)Substrate SpecificityYos9

Identifiers

PMID25086047
PMCPMC4162170
OpenAlexW1994879035

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.